Literature DB >> 23614499

Epidemiology of human infections with avian influenza A(H7N9) virus in China.

Qun Li1, Lei Zhou, Minghao Zhou, Zhiping Chen, Furong Li, Huanyu Wu, Nijuan Xiang, Enfu Chen, Fenyang Tang, Dayan Wang, Ling Meng, Zhiheng Hong, Wenxiao Tu, Yang Cao, Leilei Li, Fan Ding, Bo Liu, Mei Wang, Rongheng Xie, Rongbao Gao, Xiaodan Li, Tian Bai, Shumei Zou, Jun He, Jiayu Hu, Yangting Xu, Chengliang Chai, Shiwen Wang, Yongjun Gao, Lianmei Jin, Yanping Zhang, Huiming Luo, Hongjie Yu, Jianfeng He, Qi Li, Xianjun Wang, Lidong Gao, Xinghuo Pang, Guohua Liu, Yansheng Yan, Hui Yuan, Yuelong Shu, Weizhong Yang, Yu Wang, Fan Wu, Timothy M Uyeki, Zijian Feng.   

Abstract

BACKGROUND: The first identified cases of avian influenza A(H7N9) virus infection in humans occurred in China during February and March 2013. We analyzed data obtained from field investigations to describe the epidemiologic characteristics of H7N9 cases in China identified as of December 1, 2013.
METHODS: Field investigations were conducted for each confirmed case of H7N9 virus infection. A patient was considered to have a confirmed case if the presence of the H7N9 virus was verified by means of real-time reverse-transcriptase-polymerase-chain-reaction assay (RT-PCR), viral isolation, or serologic testing. Information on demographic characteristics, exposure history, and illness timelines was obtained from patients with confirmed cases. Close contacts were monitored for 7 days for symptoms of illness. Throat swabs were obtained from contacts in whom symptoms developed and were tested for the presence of the H7N9 virus by means of real-time RT-PCR.
RESULTS: Among 139 persons with confirmed H7N9 virus infection, the median age was 61 years (range, 2 to 91), 71% were male, and 73% were urban residents. Confirmed cases occurred in 12 areas of China. Nine persons were poultry workers, and of 131 persons with available data, 82% had a history of exposure to live animals, including chickens (82%). A total of 137 persons (99%) were hospitalized, 125 (90%) had pneumonia or respiratory failure, and 65 of 103 with available data (63%) were admitted to an intensive care unit. A total of 47 persons (34%) died in the hospital after a median duration of illness of 21 days, 88 were discharged from the hospital, and 2 remain hospitalized in critical condition; 2 patients were not admitted to a hospital. In four family clusters, human-to-human transmission of H7N9 virus could not be ruled out. Excluding secondary cases in clusters, 2675 close contacts of case patients completed the monitoring period; respiratory symptoms developed in 28 of them (1%); all tested negative for H7N9 virus.
CONCLUSIONS: Most persons with confirmed H7N9 virus infection had severe lower respiratory tract illness, were epidemiologically unrelated, and had a history of recent exposure to poultry. However, limited, nonsustained human-to-human H7N9 virus transmission could not be ruled out in four families.

Entities:  

Mesh:

Year:  2013        PMID: 23614499      PMCID: PMC6652192          DOI: 10.1056/NEJMoa1304617

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  319 in total

1.  Leveraging social networking sites for disease surveillance and public sensing: the case of the 2013 avian influenza A(H7N9) outbreak in China.

Authors:  Emma Xuxiao Zhang; Yinping Yang; Richard Di Shang; Joseph John Pyne Simons; Boon Kiat Quek; Xiao Feng Yin; Wanhan See; Olivia Seen Huey Oh; Khine Sein Tun Nandar; Vivienne Ruo Yun Ling; Pei Pei Chan; Zhaoxia Wang; Rick Siow Mong Goh; Lyn James; Jeannie Su Hui Tey
Journal:  Western Pac Surveill Response J       Date:  2015-05-18

2.  A paradigm shift in vaccine production for pandemic influenza.

Authors:  John Steel
Journal:  Ann Transl Med       Date:  2015-07

3.  Quantification of viral proteins of the avian H7 subtype of influenza virus: an isotope dilution mass spectrometry method applicable for producing more rapid vaccines in the case of an influenza pandemic.

Authors:  Wanda I Santana; Tracie L Williams; Emily K Winne; James L Pirkle; John R Barr
Journal:  Anal Chem       Date:  2014-04-11       Impact factor: 6.986

4.  Estimating the United States demand for influenza antivirals and the effect on severe influenza disease during a potential pandemic.

Authors:  Justin J O'Hagan; Karen K Wong; Angela P Campbell; Anita Patel; David L Swerdlow; Alicia M Fry; Lisa M Koonin; Martin I Meltzer
Journal:  Clin Infect Dis       Date:  2015-05-01       Impact factor: 9.079

5.  Structural analysis of the hemagglutinin from the recent 2013 H7N9 influenza virus.

Authors:  Hua Yang; Paul J Carney; Jessie C Chang; Julie M Villanueva; James Stevens
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

6.  Novel avian-origin influenza A (H7N9) virus attaches to epithelium in both upper and lower respiratory tract of humans.

Authors:  Debby van Riel; Lonneke M E Leijten; Miranda de Graaf; Jurre Y Siegers; Kirsty R Short; Monique I J Spronken; Eefje J A Schrauwen; Ron A M Fouchier; Albert D M E Osterhaus; Thijs Kuiken
Journal:  Am J Pathol       Date:  2013-09-10       Impact factor: 4.307

7.  Avian influenza viruses (AIVs) H9N2 are in the course of reassorting into novel AIVs.

Authors:  Hui-Ping Chang; Li Peng; Liang Chen; Lu-Fang Jiang; Zhi-Jie Zhang; Cheng-Long Xiong; Gen-Ming Zhao; Yue Chen; Qing-Wu Jiang
Journal:  J Zhejiang Univ Sci B       Date:  2018-05       Impact factor: 3.066

8.  Compiling of comprehensive data of human infections with novel influenza A (H7N9) virus.

Authors:  Ying Wu; George F Gao
Journal:  Front Med       Date:  2013-09       Impact factor: 4.592

9.  Structural Insight into a Human Neutralizing Antibody against Influenza Virus H7N9.

Authors:  Cong Chen; Liguo Liu; Yan Xiao; Sheng Cui; Jianmin Wang; Qi Jin
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

10.  Cross-protection of influenza A virus infection by a DNA aptamer targeting the PA endonuclease domain.

Authors:  Shuofeng Yuan; Naru Zhang; Kailash Singh; Huiping Shuai; Hin Chu; Jie Zhou; Billy K C Chow; Bo-Jian Zheng
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.